The laser allows dental professionals to expand treatment offerings, including more same-day and multiquadrant dentistry, according to a Jan. 21 news release.
The patient experience is also improved, as patients have less discomfort and anxiety and fewer appointments.
Solea laser is the only CO2 laser that is FDA-approved for all tissue indications, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
